|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.83 USD | -2.86% |
|
-4.02% | +35.85% |
| 04-30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
| 04-29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
Avid Bioservices, Inc. provided revenue guidance for the fiscal 2023. For the revenue the company expects revenue of $140 million to $145 million, a 17-21% increase over fiscal 2022.
| 1st Jan change | Capi. | |
|---|---|---|
| +35.85% | 561M | |
| -2.00% | 90.27B | |
| +1.32% | 40.12B | |
| -15.73% | 31.75B | |
| +63.31% | 26.6B | |
| -21.28% | 14.41B | |
| -8.50% | 12.92B | |
| -44.07% | 11.3B | |
| -13.06% | 11.44B | |
| +5.17% | 8.87B |
AVID BIOSERVICES, INC. 
